You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MDGL Sale Disclosure
Sibold William John · SEC Form 4 · Filed Sep 11, 2026
Sale
Calculated transaction value
$272.94K
Sibold William John President And CEO
MDGL
Transaction date
Sep 9, 2026
Public filing date
Sep 11, 2026
Filing lag
Filed 2 days later
MDGL daily price context
Close on/before transaction
$546.66
Sep 9, 2026
First close after public filing
$540.06
Sep 14, 2026
30-day return after filing
-13.5%
Through Oct 12, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 512 shares @ $533.09
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001628280-26-061581
Filing cohort
Transactions in this filing
Showing 15 of 24
Trades
24
Issuers
1
Estimated value
$6.24M
Buys / sales
0 / 24
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Sep 11, 2026 | $31.99K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Sep 11, 2026 | $56.61K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Sep 11, 2026 | $116.84K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Sep 11, 2026 | $86.02K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Sep 11, 2026 | $371.38K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Sep 11, 2026 | $199.32K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Sep 11, 2026 | $652.21K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Sep 11, 2026 | $837.25K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Sep 11, 2026 | $414.62K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Sep 11, 2026 | $65.57K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Sep 9, 2026 | $115.89K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Sep 9, 2026 | $272.8K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Sep 9, 2026 | $69.15K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Sep 9, 2026 | $86.81K |
| Madrigal Pharmaceuticals, Inc. MDGL | Sale | Sep 9, 2026 | $196.08K |